Medico Remedies Ltd.

49.27

-1.6 (-3.1%)growUp

As on January 28, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap406 Cr
P/E Ratio40.51
Dividend YieldN/A
Trendline Performance

Unlock_ipo_icon.webpUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open51
High52.5
NSE SymbolMEDICO
Close49.27
Low48.7
BSE Symbol540937
Previous Years High/Low
1 Year High79.83
3 Year High100.7
5 Year High100.7
1 Year Low37.18
3 Year Low34.8
5 Year Low16.52

Technicals


IndicatorsValueSignal
5-DMA49.5Bearish
10-DMA48.49Bullish
20-DMA48.91Bullish
50-DMA50.42Bearish
100-DMA48.58Bullish
200-DMA47.99Bullish

Historical Performance


1 Year
-32.4%
3 Years
-23%
5 Years
N/A
10 Years
N/A

Shareholding Pattern


Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:-8.3
TTM:-33
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a high PE of 40.51, indicating expensive valuation or elevated growth expectations.
  • Over the last three years, the stock delivered a weak 3-year price CAGR of -7.9%, indicating poor shareholder returns.
  • The stock carries a low beta of 0.2, suggesting lower volatility than the broader market.
  • In the last financial year, the company reported an EBITDA of ₹177 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹1509 million, suggesting a mid-sized operation.

Investment Calculator


Investment Amount:

Investment Amount: ₹ 1000000
Current Value: ₹ 670522.6
No. of Shares: 13609 (Approx)
Performance:-32.9%
P/L: ₹-329477.4
NIFTY Performance: 9.4%
1 day Top Gainers
SymbolChange%
TEJASNET339.05(15%)
DATAPATTNS2610.6(14%)
HINDCOPPER633.4(13%)
OLECTRA1088.4(10%)
SCHNEIDER697.7(10%)
1 Day Top Losers
SymbolChange%
RADICO2746.8(-6%)
HOMEFIRST1190.9(-5%)
TATACONSUM1131.8(-5%)
ASIANPAINT2511.8(-4%)
VMM119.86(-4%)
BERGEPAINT478.85(-3%)
EMCURE1435.8(-3%)
AIIL502.1(-3%)

Top Performing Stocks from the same sector


Mangalam Drugs And Organics Ltd.

68.6%

40.1

1 Month Performance

NGL Fine-Chem Ltd.

29.3%

1710.5

1 Month Performance

Ind-Swift Laboratories Ltd.

18.8%

108.7

1 Month Performance

Acutaas Chemicals Ltd.

12.7%

1862.4

1 Month Performance

Zim Laboratories Ltd.

9%

74.77

1 Month Performance

Torrent Pharmaceuticals Ltd.

3.7%

3958.7

1 Month Performance

Alkem Laboratories Ltd.

3.4%

5722.5

1 Month Performance

Alivus Life Sciences Ltd.

2.8%

932.7

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month